Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Infect Immun ; 85(2)2017 02.
Article in English | MEDLINE | ID: mdl-27872239

ABSTRACT

Mycoplasma genitalium is an underappreciated cause of human reproductive tract disease, characterized by persistent, often asymptomatic, infection. Building on our previous experiments using a single female pig-tailed macaque as a model for M. genitalium infection (G. E. Wood, S. L. Iverson-Cabral, D. L. Patton, P. K. Cummings, Y. T. Cosgrove Sweeney, and P. A. Totten, Infect Immun 81:2938-2951, 2013, https://doi.org/10.1128/IAI.01322-12), we cervically inoculated eight additional animals, two of which were simultaneously inoculated in salpingeal tissue autotransplanted into abdominal pockets. Viable M. genitalium persisted in the lower genital tract for 8 weeks in three animals, 4 weeks in two, and 1 week in one; two primates resisted infection. In both animals inoculated in salpingeal pockets, viable M. genitalium was recovered for 2 weeks. Recovery of viable M. genitalium from lower genital tract specimens was improved by diluting the specimen in broth and by Vero cell coculture. Ascension to upper reproductive tract tissues was not detected, even among three persistently infected animals. M. genitalium-specific serum antibodies targeting the immunodominant MgpB and MgpC proteins appeared within 1 week in three animals inoculated both cervically and in salpingeal pockets and in one of three persistently infected animals inoculated only in the cervix. M. genitalium-specific IgG, but not IgA, was detected in cervical secretions of serum antibody-positive animals, predominantly against MgpB and MgpC, but was insufficient to clear M. genitalium lower tract infection. Our findings further support female pig-tailed macaques as a model of M. genitalium infection, persistence, and immune evasion.


Subject(s)
Mycoplasma Infections/microbiology , Mycoplasma genitalium , Animals , Antibodies, Bacterial/blood , Antibodies, Bacterial/immunology , Bacterial Load , Biopsy , Cell Line , Cervix Uteri/microbiology , Disease Models, Animal , Female , Genitalia, Female/microbiology , Immunoglobulin G/blood , Immunoglobulin G/immunology , Macaca nemestrina , Monkey Diseases/microbiology , Mycoplasma Infections/pathology , Mycoplasma genitalium/immunology
2.
Infect Immun ; 81(8): 2938-51, 2013 Aug.
Article in English | MEDLINE | ID: mdl-23732170

ABSTRACT

Mycoplasma genitalium is a sexually transmitted pathogen associated with several acute and chronic reproductive tract disease syndromes in men and women. To evaluate the suitability of a pig-tailed macaque model of M. genitalium infection, we inoculated a pilot animal with M. genitalium strain G37 in the uterine cervix and in salpingeal pockets generated by transplanting autologous Fallopian tube tissue subcutaneously. Viable organisms were recovered throughout the 8-week experiment in cervicovaginal specimens and up to 2 weeks postinfection in salpingeal pockets. Humoral and cervicovaginal antibodies reacting to MgpB were induced postinoculation and persisted throughout the infection. The immunodominance of the MgpB adhesin and the accumulation of mgpB sequence diversity previously observed in persistent human infections prompted us to evaluate sequence variation in this animal model. We found that after 8 weeks of infection, sequences within mgpB variable region B were replaced by novel sequences generated by reciprocal recombination with an archived variant sequence located elsewhere on the chromosome. In contrast, mgpB region B of the same inoculum propagated for 8 weeks in vitro remained unchanged. Notably, serum IgG reacted strongly with a recombinant protein spanning MgpB region B of the inoculum, while reactivity to a recombinant protein representing the week 8 variant was reduced, suggesting that antibodies were involved in the clearance of bacteria expressing the original infecting sequence. Together these results suggest that the pig-tailed macaque is a suitable model to study M. genitalium pathogenesis, antibody-mediated selection of antigenic variants in vivo, and immune escape.


Subject(s)
Adhesins, Bacterial/immunology , Disease Models, Animal , Macaca nemestrina , Mycoplasma Infections/immunology , Mycoplasma genitalium/immunology , Adhesins, Bacterial/genetics , Animals , Antibodies, Bacterial/blood , Antibodies, Bacterial/immunology , Antigens, Bacterial/genetics , Antigens, Bacterial/immunology , Enzyme-Linked Immunosorbent Assay , Female , Immunoblotting , Molecular Sequence Data , Mycoplasma genitalium/genetics , Reverse Transcriptase Polymerase Chain Reaction
3.
J Med Primatol ; 40(5): 327-34, 2011 Oct.
Article in English | MEDLINE | ID: mdl-21443565

ABSTRACT

BACKGROUND: Inclusion of sexual activity in the macaque model for topical microbicide safety evaluation would more closely mimic human use of topical microbicides and provide a more rigorous safety assessment. METHODS: Initially, male-female partners were monitored in cohousing arrangements to determine whether macaques would copulate ad libitum. The logistics of performing vaginal examinations before and after coital visits were analyzed and optimized. Findings from cervicovaginal examinations conducted before and after sexual activity were compared. RESULTS: Coital activity was reliably observed in the majority of cohousing sessions, representing all phases of the menstrual cycle. Female macaques were trained to be restrained while fully alert for pre-coital vaginal sampling. Post-coital examinations occur under general sedation. Post-coital examinations reveal alterations to tissues, microbiology, and pH compared with pre-coital visits. CONCLUSIONS: This work clearly demonstrates that it is feasible to incorporate sexual activity in the macaque model for topical microbicide safety assessment.


Subject(s)
Anti-Infective Agents, Local/adverse effects , Copulation , Disease Models, Animal , Gynecological Examination/veterinary , Macaca nemestrina , Sexually Transmitted Diseases/prevention & control , Vagina/drug effects , Administration, Intravaginal , Animals , Anti-Infective Agents, Local/administration & dosage , Anti-Infective Agents, Local/pharmacology , Drug Evaluation, Preclinical/veterinary , Female , Male , Sexually Transmitted Diseases/drug therapy , Sexually Transmitted Diseases/microbiology , Vagina/microbiology , Vagina/physiology
SELECTION OF CITATIONS
SEARCH DETAIL
...